Alkeus Pharmaceuticals’ study results from Gildeuretinol shows significant trend in slowing geographic atrophy: Cambridge, Massachusetts Friday, October 25, 2024, 10:00 Hrs [IST ...
Indian CROs well integrated with electronic systems as US FDA issues new guidelines regarding electronic records: Nandita Vijayasimha, Bengaluru Friday, October 25, 2024, 08:00 Hr ...
Peethaambaran Kunnathoor, Chennai. Friday, October 25, 2024, 08:00 Hrs [IST] ...
Merck’s Keytruda receives European approval for two new indications in gynaecologic cancers: Rahway, New Jersey Friday, October 25, 2024, 09:00 Hrs [IST] Merck, known as MSD out ...
PCI requests all pharmacy institutions to register with NAD/ABC: Our Bureau, New Delhi Friday, October 25, 2024, 08:00 Hrs ...
Delhi HC refuses Abbott's appeal in trade mark dispute on pain killer drug Mebufen: Gireesh Babu, New Delhi Friday, October 25, 2024, 08:00 Hrs [IST] The Delhi High Court has orde ...
Pharmexcil calls on members to enroll as voters for 2024-26 elections: Shardul Nautiyal, Mumbai Friday, October 25, 2024, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Coun ...
Strides in Q2FY25 reports revenues Rs. 1,201.1 crore up 17% PAT Rs. 93.7 crore: Our Bureau, Bengaluru Thursday, October 24, 2024, 17:10 Hrs [IST] Strides Pharma Science in its Q2 ...
Dr Agarwals Eye Hospital notes 15-20% of total impaired vision in Karnataka due to corneal blindness
Our Bureau, Bengaluru Thursday, October 24, 2024, 17:30 Hrs [IST] ...
Our Bureau, Bengaluru Thursday, October 24, 2024, 17:20 Hrs [IST] ...
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...
Repare Therapeutics reports updated positive safety and tolerability results from phase 1 MYTHIC trial: Cambridge, Massachusetts Thursday, October 24, 2024, 18:00 Hrs [IST] Repare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback